Pediatric Campylobacter Infections Treatment & Management

  • Author: Jocelyn Y Ang, MD; Chief Editor: Russell W Steele, MD   more...
 
Updated: Aug 29, 2011
 

Medical Care

  • Evaluation of patients with Campylobacter infections can usually be performed on an outpatient basis.
  • Intravenous hydration and inpatient care may be necessary for patients who are severely dehydrated and cannot tolerate oral hydration.
Next

Surgical Care

  • Occasionally, acute abdominal pain may be the only presenting symptom, often mimicking acute appendicitis and resulting in immediate laparotomy.
Previous
Next

Consultations

  • Consultation with an infectious disease specialist and a gastroenterologist may be necessary for complicated cases.
Previous
Next

Diet

  • Because rehydration and electrolyte replacement are the mainstays for treating diarrheal disease, oral rehydration with an electrolyte and glucose solution is necessary.
Previous
Next

Activity

  • Permit activity as tolerated.
Previous
Proceed to Medication
 
 
Contributor Information and Disclosures
Author

Jocelyn Y Ang, MD  Assistant Professor, Department of Pediatrics, Division of Infectious Diseases, Children's Hospital of Michigan and Wayne State University

Jocelyn Y Ang, MD is a member of the following medical societies: American Academy of Pediatrics, Infectious Diseases Society of America, and Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Coauthor(s)

Sharon Nachman  MD, Professor of Pediatrics, Associate Dean for Research

Sharon Nachman is a member of the following medical societies: American Academy of Pediatrics, American Society for Microbiology, Infectious Diseases Society of America, and Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Itzhak Brook, MD, MSc  Professor, Department of Pediatrics, Georgetown University School of Medicine

Itzhak Brook, MD, MSc is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians-American Society of Internal Medicine, American Federation for Clinical Research, American Medical Association, American Society for Microbiology, Armed Forces Infectious Diseases Society, Association of Military Surgeons of the US, Infectious Diseases Society of America, International Immunocompromised Host Society, International Society for Infectious Diseases, Medical Society of the District of Columbia, New York Academy of Sciences, Pediatric Infectious Diseases Society, Society for Ear, Nose and Throat Advances in Children, Society for Experimental Biology and Medicine, Society for Pediatric Research, Southern Medical Association, and Surgical Infection Society

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Mark R Schleiss, MD  American Legion Chair of Pediatrics, Professor of Pediatrics, Division Director, Division of Infectious Diseases and Immunology, Department of Pediatrics, University of Minnesota Medical School

Mark R Schleiss, MD is a member of the following medical societies: American Pediatric Society, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and Society for Pediatric Research

Disclosure: Nothing to disclose.

Robert W Tolan Jr, MD  Chief, Division of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine

Robert W Tolan Jr, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Phi Beta Kappa, and Physicians for Social Responsibility

Disclosure: GlaxoSmithKline Honoraria Speaking and teaching; MedImmune Honoraria Speaking and teaching; Merck Honoraria Speaking and teaching; Sanofi Pasteur Honoraria Speaking and teaching; Baxter Healthcare Honoraria Speaking and teaching; Novartis Honoraria Speaking and teaching

Chief Editor

Russell W Steele, MD  Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association

Disclosure: Nothing to disclose.

References

  1. Zilbauer M, Dorrell N, Wren BW, Bajaj-Elliott M. Campylobacter jejuni-mediated disease pathogenesis: an update. Trans R Soc Trop Med Hyg. Feb 2008;102(2):123-9. [Medline].

  2. Allos BM. Campylobacter jejuni Infections: update on emerging issues and trends. Clin Infect Dis. Apr 15 2001;32(8):1201-6. [Medline].

  3. CDC. Vital signs: incidence and trends of infection with pathogens transmitted commonly through food--foodborne diseases active surveillance network, 10 U.S. sites, 1996-2010. MMWR Morb Mortal Wkly Rep. Jun 10 2011;60(22):749-55. [Medline].

  4. Feierl G, Jelovcan S. Campylobacteriosis in Austria: situation and trends. Wien Klin Wochenschr. 2009;121(3-4):103-7. [Medline].

  5. Jafari F, Garcia-Gil LJ, Salmanzadeh-Ahrabi S, Shokrzadeh L, Aslani MM, Pourhoseingholi MA. Diagnosis and prevalence of enteropathogenic bacteria in children less than 5 years of age with acute diarrhea in Tehran children's hospitals. J Infect. Jan 2009;58(1):21-7. [Medline].

  6. Wang SC, Chang LY, Hsueh PR, et al. Campylobacter enteritis in children in northern Taiwan--a 7-year experience. J Microbiol Immunol Infect. 2008;41(5):408-413.

  7. Soofi SB, Habib MA, von Seidlein L, et al. A comparison of disease caused by Shigella and Campylobacter species: 24 months community based surveillance in 4 slums of Karachi, Pakistan. J Infect Public Health. Mar 2011;4(1):12-21. [Medline].

  8. Yang JR, Wu HS, Chiang CS, Mu JJ. Pediatric campylobacteriosis in northern Taiwan from 2003 to 2005. BMC Infect Dis. 2008;8:151. [Medline].

  9. Gillespie IA, O'Brien SJ, Penman C, Tompkins D, Cowden J, Humphrey TJ. Demographic determinants for Campylobacter infection in England and Wales: implications for future epidemiological studies. Epidemiol Infect. Dec 2008;136(12):1717-25. [Medline].

  10. Samuel MC, Vugia DJ, Shallow S, et al. Epidemiology of sporadic Campylobacter infection in the United States and declining trend in incidence, FoodNet 1996-1999. Clin Infect Dis. 2004;38 Suppl 3:S165-174.

  11. Coker AO, Isokpehi RD, Thomas BN, Amisu KO, Obi CL. Human campylobacteriosis in developing countries. Emerg Infect Dis. Mar 2002;8(3):237-44. [Medline].

  12. Sorokin M, Usein CR, Irimia M, Damian M. A laboratory-based survey of Campylobacter infections in Prahova County. Roum Arch Microbiol Immunol. Jul-Dec 2007;66(3-4):85-9. [Medline].

  13. Pacanowski J, Lalande V, Lacombe K, Boudraa C, Lesprit P, Legrand P. Campylobacter bacteremia: clinical features and factors associated with fatal outcome. Clin Infect Dis. Sep 15 2008;47(6):790-6. [Medline].

  14. Tee W, Mijch A. Campylobacter jejuni bacteremia in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients: comparison of clinical features and review. Clin Infect Dis. Jan 1998;26(1):91-6. [Medline].

  15. Blaser MJ. Extraintestinal Campylobacter infections. West J Med. Mar 1986;144(3):353-4. [Medline].

  16. Uzoigwe C. Campylobacter infections of the pericardium and myocardium. Clin Microbiol Infect. Apr 2005;11(4):253-5. [Medline].

  17. Fujihara N, Takakura S, Saito T, Iinuma Y, Ichiyama S. A case of perinatal sepsis by Campylobacter fetus subsp. fetus infection successfully treated with carbapenem--case report and literature review. J Infect. 2006;53(5):e199-202.

  18. Simor AE, Karmali MA, Jadavji T, Roscoe M. Abortion and perinatal sepsis associated with campylobacter infection. Rev Infect Dis. May-Jun 1986;8(3):397-402. [Medline].

  19. Krishnaswamy R, Sasidharan P, Rejjal A, Osba YA. Early onset neonatal sepsis with Campylobacter jejuni: a case report. Eur J Pediatr. Feb 1991;150(4):277-8. [Medline].

  20. Gazaigne L, Legrand P, Renaud B, Bourra B, Taillandier E, Brun-Buisson C. Campylobacter fetus bloodstream infection: risk factors and clinical features. Eur J Clin Microbiol Infect Dis. Mar 2008;27(3):185-9. [Medline].

  21. Bessede E, Delcamp A, Sifre E, et al. New methods for detection of campylobacters in stool samples in comparison to culture. J Clin Microbiol. Mar 2011;49(3):941-4. [Medline].

  22. Mee AS, Shield M, Burke M. Campylobacter colitis: differentiation from acute inflammatory bowel disease. J R Soc Med. Mar 1985;78(3):217-23. [Medline].

  23. Ternhag A, Asikainen T, Giesecke J, Ekdahl K. A meta-analysis on the effects of antibiotic treatment on duration of symptoms caused by infection with Campylobacter species. Clin Infect Dis. Mar 1 2007;44(5):696-700. [Medline].

  24. Alfredson DA, Korolik V. Antibiotic resistance and resistance mechanisms in Campylobacter jejuni and Campylobacter coli. FEMS Microbiol Lett. Dec 2007;277(2):123-32. [Medline].

  25. Valenza G, Frosch M, Abele-Horn M. Antimicrobial susceptibility of clinical Campylobacter isolates collected at a German university hospital during the period 2006-2008. Scand J Infect Dis. 2010;42(1):57-60. [Medline].

  26. Ewnetu D, Mihret A. Prevalence and antimicrobial resistance of Campylobacter isolates from humans and chickens in Bahir Dar, Ethiopia. Foodborne Pathog Dis. Jun 2010;7(6):667-70. [Medline].

  27. Tremblay C, Gaudreau C. Antimicrobial susceptibility testing of 59 strains of Campylobacter fetus subsp. fetus. Antimicrob Agents Chemother. Jul 1998;42(7):1847-9. [Medline].

  28. Tremblay C, Gaudreau C, Lorange M. Epidemiology and antimicrobial susceptibilities of 111 Campylobacter fetus subsp. fetus strains isolated in Quebec, Canada, from 1983 to 2000. J Clin Microbiol. Jan 2003;41(1):463-6. [Medline].

  29. Yuki N. Campylobacter sialyltransferase gene polymorphism directs clinical features of Guillain-Barré syndrome. J Neurochem. Nov 2007;103 Suppl 1:150-8. [Medline].

  30. McKhann GM, Cornblath DR, Griffin JW, Ho TW, Li CY, Jiang Z. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol. Apr 1993;33(4):333-42. [Medline].

  31. Pope JE, Krizova A, Garg AX, Thiessen-Philbrook H, Ouimet JM. Campylobacter reactive arthritis: a systematic review. Semin Arthritis Rheum. Aug 2007;37(1):48-55. [Medline].

  32. Peterson MC. Rheumatic manifestations of Campylobacter jejuni and C. fetus infections in adults. Scand J Rheumatol. 1994;23(4):167-70. [Medline].

  33. Hannu T, Mattila L, Rautelin H, Pelkonen P, Lahdenne P, Siitonen A. Campylobacter-triggered reactive arthritis: a population-based study. Rheumatology (Oxford). Mar 2002;41(3):312-8. [Medline].

  34. Blaser MJ, Perez GP, Smith PF, Patton C, Tenover FC, Lastovica AJ. Extraintestinal Campylobacter jejuni and Campylobacter coli infections: host factors and strain characteristics. J Infect Dis. Mar 1986;153(3):552-9. [Medline].

  35. Braun KP, Theissig F, Ernst H, May M, Krulls-Munch J. [Campylobacter-jejuni-associated hepatitis and myocardial injury]. Med Klin (Munich). May 15 2008;103(5):346-8. [Medline].

  36. [Guideline] Diagnosis and management of foodborne illnesses: a primer for physicians and other health care professionals. MMWR Recomm Rep. Apr 16 2004;53:1-33. [Medline].

  37. Godschalk PC, Kuijf ML, Li J, St et al. Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes. Infect Immun. 2007;75(3):1245-1254.

  38. Luquero Alcalde FJ, Sanchez Padilla E, Eiros Bouza JM, et al. [Trend and seasonal variations of Campylobacter gastroenteritis in Valladolid, Spain. A five-year series, 2000-2004]. Rev Esp Salud Publica. 2007;81(3):319-326.

  39. Peterson MC. Clinical aspects of Campylobacter jejuni infections in adults. West J Med. Aug 1994;161(2):148-52. [Medline].

  40. Roan JN, Ko WC, Luo CY. Abdominal septic aortic pseudoaneurysm caused by Campylobacter jejuni infection: report of a case. Surg Today. 2009;39(2):137-40. [Medline].

  41. Tokuda K, Nishi J, Miyanohara H, Sarantuya J, Iwashita M, Kamenosono A. Relapsing cellulitis associated with Campylobacter coli bacteremia in an agammaglobulinemic patient. Pediatr Infect Dis J. Jun 2004;23(6):577-9. [Medline].

 
Previous
Next
 
Scanning electron microscope image of Campylobacter jejuni, illustrating its corkscrew appearance and bipolar flagella. Source: Virginia-Maryland Regional College of Veterinary Medicine, Blacksburg, Virginia.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.